Free Trial

NeoGenomics (NEO) SEC Filings & 10K Form

$16.04
-0.17 (-1.05%)
(As of 09/6/2024 ET)

Recent NeoGenomics SEC Filings

DateFilerForm TypeView
08/15/2024
3:29 PM
NeoGenomics (Subject)
Olivo Alicia C (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2024
3:12 PM
CROWTHER BRUCE K (Reporting)
NeoGenomics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
3:32 PM
Kelly Michael Aaron (Reporting)
NeoGenomics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:34 PM
NeoGenomics (Issuer)
Perez David Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:37 PM
NeoGenomics (Issuer)
TETRAULT LYNN A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:40 PM
NeoGenomics (Issuer)
Zook Anthony P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:21 PM
Gunn Neil (Reporting)
NeoGenomics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:17 PM
Floegel Elizabeth (Reporting)
NeoGenomics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:08 PM
NeoGenomics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/15/2024
3:23 PM
NeoGenomics (Subject)
Olivo Alicia C (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2024
8:38 PM
Harris Melody (Reporting)
NeoGenomics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
8:38 PM
NeoGenomics (Issuer)
Sherman Jeffrey Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
8:38 PM
NeoGenomics (Issuer)
Stone Warren (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
8:39 PM
NeoGenomics (Issuer)
Olivo Alicia C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
8:39 PM
NeoGenomics (Issuer)
Smith Christopher M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
6:32 AM
NeoGenomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2024
6:00 AM
NeoGenomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2024
3:26 PM
NeoGenomics (Filer)
Form ARS
02/09/2024
2:17 PM
BROWN ADVISORY INC (Filed by)
NeoGenomics (Subject)
Form SC 13G/A
01/03/2024
4:28 PM
Harris Melody (Reporting)
NeoGenomics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
6:54 PM
NeoGenomics (Issuer)
Sherman Jeffrey Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
3:49 PM
NeoGenomics (Issuer)
Stone Warren (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
3:33 PM
NeoGenomics (Issuer)
Olivo Alicia C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
3:25 PM
NeoGenomics (Subject)
Olivo Alicia C (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2023
3:29 PM
NeoGenomics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2023
3:18 PM
NeoGenomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2023
4:50 PM
NeoGenomics (Issuer)
Olivo Alicia C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:NEO) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners